JYMed tau txais txiaj ntsig European patent rau nws txoj kev sib txuas tshiab ntawm Liraglutide. Lub ntsiab lus tseem ceeb no qhia txog peb txoj kev coj ua txuas ntxiv hauv peptide R & D thiab IP. Cov patent no sawv cev rau cov txheej txheem tshiab rau kev sib txuas ntawm liraglutide, uas tsis tsuas yog ua kom ruaj khov yield tab sis kuj txo qis kev tsim ntawm racemic impurity [D-Thr^5]-Liraglutide, uas zoo sib xws rau cov khoom lag luam. Qhov kev tsim kho tshiab no txhim kho tag nrho cov khoom zoo.

Kev nrhiav tau ntawm European patent no qhia txog kev R & D muaj peev xwm ntawm lub tuam txhab, ntxiv dag zog rau nws cov txiaj ntsig thev naus laus zis. Nws txhawb nqa JYMed qhov tseem ceeb ntawm kev sib tw thiab nthuav nws lub xub ntiag hauv kev lag luam thoob ntiaj teb. Tsis tas li ntawd, nws txhawb nqa lub tuam txhab cov cuab yeej cuab tam zoo, pab tswj thiab txhim kho nws txoj kev lag luam thoob ntiaj teb kev sib tw.

Hubei JXBio Pharmaceutical Co., Ltd, lub chaw muag khoom ntawm Shenzhen JYMed Technology Co., Ltd, tsis ntev los no tau txais Daim Ntawv Pom Zoo Kev Lag Luam rau Oxytocin Active Pharmaceutical Ingredient (API) tawm los ntawm National Medical Products Administration (NMPA) ntawm Tuam Tshoj.

Qhov kev pom zoo no qhia tau hais tias JXBio's oxytocin API ua tau raws li kev cai tswj hwm kev cai tsim los ntawm lub teb chaws tshuaj ntsuam xyuas. Nws yog lub hauv paus tseem ceeb rau lub tuam txhab, ntxiv dag zog rau nws cov khoom lag luam thiab muab lub hauv paus muaj zog rau kev nthuav dav kev lag luam hauv oxytocin sector.
Hais txog JYMED
JYMed yog lub tuam txhab thev naus laus zis biopharmaceutical tshwj xeeb hauv kev tshawb fawb ywj pheej, kev tsim kho, tsim khoom, thiab muag cov khoom siv peptide, nrog rau kev cog lus tsim kho thiab tsim cov koom haum (CDMO) cov kev pabcuam. Lub tuam txhab tau cog lus los muab cov khoom zoo peptide APIs thiab cov kev daws teeb meem rau cov neeg siv khoom thoob ntiaj teb. Nws cov khoom lag luam suav nrog ntau ntau ntawm peptide APIs, nrog rau cov khoom tseem ceeb xws li Semaglutide thiab Terlipressin tau ua tiav US FDA DMF cov ntaub ntawv.

Nws cov chaw muag khoom, Hubei JXBio Pharmaceutical Co., Ltd., ua haujlwm hauv xeev-of-the-art peptide API cov kab ntau lawm uas ua raws li cGMP cov qauv tsim los ntawm US FDA, European EMA, thiab Tuam Tshoj NMPA. Lub chaw muaj xws li 10 loj-scale thiab pilot ntau lawm kab thiab tau tsim ib tug nruj kev tswj xyuas cov tshuaj zoo (QMS) thiab ib puag ncig kev noj qab haus huv thiab kev nyab xeeb (EHS) system. Cov no xyuas kom meej tias tag nrho cov txheej txheem, los ntawm R & D mus rau ntau lawm, ua tau raws li cov qauv thoob ntiaj teb siab tshaj plaws. Lub tuam txhab tau ua tiav GMP kev soj ntsuam xyuas los ntawm US FDA thiab Tuam Tshoj NMPA thiab tau lees paub los ntawm cov tuam txhab tshuaj thoob ntiaj teb rau nws txoj kev tswj hwm EHS zoo, ua kom pom nws txoj kev cog lus zoo, kev nyab xeeb, thiab lub luag haujlwm ib puag ncig.

Cov lag luam tseem ceeb:Hauv tsev thiab thoob ntiaj teb peptide API rau npe thiab ua raws,Veterinary thiab cosmetic peptides,Kev pabcuam peptide, suav nrog CRO, CMO, thiab OEM kev daws teeb meem,Peptide-drug conjugates (PDCs), suav nrog peptide-radionuclide, peptide-me me molecule, peptide-protein, thiab peptide-RNA therapeutics.

MAIN khoom

Yog xav paub ntxiv txog peb cov khoom, thov hu rau peb.

Ntiaj teb no API thiab Cosmetic Inquiries: Tel No.: +86-15013529272;

API Registration & CDMO Services (USA EU market): +86-15818682250

E-mail:jymed@jymedtech.com

Chaw nyob: Floors 8 & 9, Building 1, Shenzhen Biomedical Innovation Industrial Park, 14 Jinhui Road, Kengzi District, Pingshan District, Shenzhen